Rajanikanth BR, Rao KS, Sharma SM, Rajendra Prasad B
It activates the Nrf2 pathway, a master regulator that upregulates multiple antioxidant enzymes simultaneously, creating a comprehensive antioxidant response
Not just chemistry, but biology, precision design, and regulatory depth are now becoming essential to compete in this space." Hari Kiran Chereddi, MD & CEO, HRV Pharma and NHG Pharma GLP-1 Patent Expiry Timeline and Market Dynamics The market opportunity is defined by several critical factors: Patent Expiration: Semaglutide's key patents expire globally by early 2026 Market Growth: Demand for obesity and diabetes treatments growing 12-14% year-over-year Healthcare Savings: Indian companies can save global healthcare systems billions through cost-effective alternatives Regulatory Access: Opportunities to develop biosimilars or complex generics for US and EU markets Beyond Cost Competition: Value-Based Differentiation The competitive landscape for GLP-1 drugs extends beyond traditional cost advantages that have historically defined Indian pharmaceutical success
about 13% were Black veterans and 4% were listed as other
The potential physical effects of BPC-157 may boost other areas of psychological health
